Andre CHOLLET

Person

Plan-les-Ouates, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Oral formulations of pyrrolidine derivatives
- Patent number 11,419,851
- Issue date Aug 23, 2022
- ObsEva S.A.
- Andre Chollet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antag...
- Patent number 11,312,683
- Issue date Apr 26, 2022
- ObsEva S.A.
- Andre Chollet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antag...
- Patent number 10,604,482
- Issue date Mar 31, 2020
- ObsEva S.A.
- Andre Chollet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oral formulations of pyrrolidine derivatives
- Patent number 10,478,420
- Issue date Nov 19, 2019
- ObsEva S.A.
- Andre Chollet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antag...
- Patent number 10,047,048
- Issue date Aug 14, 2018
- ObsEva S.A.
- Andre Chollet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations of pyrrolidine derivatives
- Patent number 9,962,367
- Issue date May 8, 2018
- ObsEva S.A.
- Andre Chollet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...
- Publication number 20240228439
- Publication date Jul 11, 2024
- ObsEva S.A.
- Andre CHOLLET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
- Publication number 20230226021
- Publication date Jul 20, 2023
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...
- Publication number 20230097933
- Publication date Mar 30, 2023
- ObsEva S.A.
- Andre CHOLLET
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...
- Publication number 20210047266
- Publication date Feb 18, 2021
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
- Publication number 20200281892
- Publication date Sep 10, 2020
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
- Publication number 20180311211
- Publication date Nov 1, 2018
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...
- Publication number 20180215708
- Publication date Aug 2, 2018
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...
- Publication number 20170240508
- Publication date Aug 24, 2017
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
- Publication number 20170065556
- Publication date Mar 9, 2017
- ObsEva S.A.
- Andre Chollet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
- Publication number 20150164859
- Publication date Jun 18, 2015
- ObsEva S.A.
- Andre CHOLLET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Andre CHOLLET

Person

Patents Grantslast 30 patents

Oral formulations of pyrrolidine derivatives

Pyrrolidine derivatives as oxytocin/vasopressin via receptors antag...

Pyrrolidine derivatives as oxytocin/vasopressin via receptors antag...

Oral formulations of pyrrolidine derivatives

Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antag...

Oral formulations of pyrrolidine derivatives

Patents Applicationslast 30 patents

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...

PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAG...

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES